Increased expression of membrane type 1 matrix metalloproteinase and matrix metalloproteinase-2 with tumor dedifferentiation in hepatocellular carcinomas
被引:46
|
作者:
Ogata, R
论文数: 0引用数: 0
h-index: 0
机构:Kurume Univ, Sch Med, Dept Med 2, Kurume, Fukuoka 8300011, Japan
Ogata, R
Torimura, T
论文数: 0引用数: 0
h-index: 0
机构:Kurume Univ, Sch Med, Dept Med 2, Kurume, Fukuoka 8300011, Japan
Torimura, T
Kin, M
论文数: 0引用数: 0
h-index: 0
机构:Kurume Univ, Sch Med, Dept Med 2, Kurume, Fukuoka 8300011, Japan
Kin, M
Ueno, T
论文数: 0引用数: 0
h-index: 0
机构:Kurume Univ, Sch Med, Dept Med 2, Kurume, Fukuoka 8300011, Japan
Ueno, T
Tateishi, Y
论文数: 0引用数: 0
h-index: 0
机构:Kurume Univ, Sch Med, Dept Med 2, Kurume, Fukuoka 8300011, Japan
Tateishi, Y
Kuromatsu, R
论文数: 0引用数: 0
h-index: 0
机构:Kurume Univ, Sch Med, Dept Med 2, Kurume, Fukuoka 8300011, Japan
Kuromatsu, R
Shimauchi, Y
论文数: 0引用数: 0
h-index: 0
机构:Kurume Univ, Sch Med, Dept Med 2, Kurume, Fukuoka 8300011, Japan
Shimauchi, Y
Sakamoto, M
论文数: 0引用数: 0
h-index: 0
机构:Kurume Univ, Sch Med, Dept Med 2, Kurume, Fukuoka 8300011, Japan
Sakamoto, M
Tamaki, S
论文数: 0引用数: 0
h-index: 0
机构:Kurume Univ, Sch Med, Dept Med 2, Kurume, Fukuoka 8300011, Japan
Tamaki, S
Sata, M
论文数: 0引用数: 0
h-index: 0
机构:Kurume Univ, Sch Med, Dept Med 2, Kurume, Fukuoka 8300011, Japan
Sata, M
Tanikawa, K
论文数: 0引用数: 0
h-index: 0
机构:Kurume Univ, Sch Med, Dept Med 2, Kurume, Fukuoka 8300011, Japan
Tanikawa, K
机构:
[1] Kurume Univ, Sch Med, Dept Med 2, Kurume, Fukuoka 8300011, Japan
[2] Res Innovat Canc Therapy, Liver Canc Res Div, Kurume, Fukuoka, Japan
[3] Kurume Res Ctr, Int Inst Liver Res, Kurume, Fukuoka, Japan
MT-MMP;
MMP-2;
HCC;
immunohistochemistry;
in situ hybridization;
gelatin zymography;
D O I:
10.1016/S0046-8177(99)90121-1
中图分类号:
R36 [病理学];
学科分类号:
100104 ;
摘要:
Destruction of the extracellular matrices is required for tumor invasion and metastasis. Matrix metalloproteinase-2 degrades type IV collagen and laminin, major components of the basement membrane. Membrane type 1 matrix metalloproteinase activates the latent form of matrix metalloproteinase-2. We studied changes in membrane type 1 matrix metalloproteinase and matrix metalloproteinase-2 expression in relation to the tumor differentiation of hepatocellular carcinomas. Activity of matrix metalloproteinase-2 was also evaluated in hepatocellular carcinomas and noncancerous tissues. Overall, 37 hepatocellular carcinomas were studied. Expression of membrane type 1 matrix metalloproteinase and matrix metalloproteinase-2 was determined by either immunohistochemistry (n = 37) or in situ hybridization (n = 6). Changes in membrane type 1 matrix metalloproteinase and matrix metalloproteinase-2 expression were evaluated in relation to tumor differentiation. Gelatinolytic activities were analyzed by gelatin zymography (n = 4). Membrane type 1 matrix metalloproteinase and matrix metalloproteinase-2 were detected in hepatoma cells and stromal cells. In addition, these matrix metalloaro-teinases were detected in the same hepatoma cells. Increased expression of membrane type 1 matrix metalloproteinase and matrix metalloproteinase-2 was associated with tumor dedifferentiation. The active form of matrix metalloproteinase-2 was more strongly expressed by hepatocellular carcinomas than by noncancerous tissues. These findings indicate that increased expression of membrane type 1 matrix metalloproteinase and matrix metalloproteinase-2 was associated with tumor dedifferentiation, suggesting that these matrix metalloproteinases are intimately involved in the invasion of hepatocellular carcinomas. Copyright (C) 1999 by W.B. Saunders Company.